Biosimilar and innovator anti-Tumour Necrosis Factor (TNF) or lymphocyte trafficking blockade: Which one to select?

Journal article

Open access

Peer reviewed

Journal of gastroenterology and hepatology, Vol.31(S1), pp.24-25

01/06/2016

Handle:

https://hdl.handle.net/10523/39626

Abstract

Gastroenterology & Hepatology

Life Sciences & Biomedicine

Science & Technology

url

https://doi.org/10.1111/jgh.13357View

Published (Version of record) Open

8 Record Views

Record Identifier: 9926549627401891
Title: Biosimilar and innovator anti-Tumour Necrosis Factor (TNF) or lymphocyte trafficking blockade: Which one to select?
Creators: Richard B. Gearry
Publication Details: Journal of gastroenterology and hepatology, Vol.31(S1), pp.24-25
Academic Unit: Medicine (UOC)
Publisher: Wiley
Date published ; e-published: 01/06/2016
Language: English
Resource Type ; Subtype: Journal article